Iteos Therapeutics Stock Technical Analysis
| ITOS Stock | USD 10.13 0.00 0.00% |
As of the 21st of July, Iteos Therapeutics retains the Market Risk Adjusted Performance of 3.58, downside deviation of 2.35, and Risk Adjusted Performance of 0.2374. Iteos Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Iteos Therapeutics mean deviation, information ratio, as well as the relationship between the Information Ratio and downside variance to decide if Iteos Therapeutics is priced fairly, providing market reflects its last-minute price of 10.13 per share. Given that Iteos Therapeutics has jensen alpha of 0.9747, we strongly advise you to confirm Iteos Therapeutics's regular market performance to make sure the company can sustain itself at a future point.
Iteos Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Iteos, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IteosIteos Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Iteos Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 23.5 | Strong Buy | 6 | Odds |
Most Iteos analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Iteos stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Iteos Therapeutics, talking to its executives and customers, or listening to Iteos conference calls.
Iteos Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Iteos Therapeutics Technical Analysis
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Normalized Average True Range is used to analyze tradable apportunities for Iteos Therapeutics across different markets.
Iteos Therapeutics Trend Analysis
Use this graph to draw trend lines for Iteos Therapeutics. You can use it to identify possible trend reversals for Iteos Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Iteos Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Iteos Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Iteos Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.06 , which means Iteos Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 155.43, which is the sum of squared deviations for the predicted Iteos Therapeutics price change compared to its average price change.About Iteos Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Iteos Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Iteos Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Iteos Therapeutics price pattern first instead of the macroeconomic environment surrounding Iteos Therapeutics. By analyzing Iteos Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Iteos Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Iteos Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 3.32 | 188.37 | 38.49 | 48.6 | PTB Ratio | 1.05 | 0.68 | 0.53 | 0.5 |
Iteos Therapeutics July 21, 2025 Technical Indicators
Most technical analysis of Iteos help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Iteos from various momentum indicators to cycle indicators. When you analyze Iteos charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2374 | |||
| Market Risk Adjusted Performance | 3.58 | |||
| Mean Deviation | 2.77 | |||
| Semi Deviation | 1.83 | |||
| Downside Deviation | 2.35 | |||
| Coefficient Of Variation | 406.68 | |||
| Standard Deviation | 4.16 | |||
| Variance | 17.27 | |||
| Information Ratio | 0.212 | |||
| Jensen Alpha | 0.9747 | |||
| Total Risk Alpha | 0.4299 | |||
| Sortino Ratio | 0.3745 | |||
| Treynor Ratio | 3.57 | |||
| Maximum Drawdown | 20.47 | |||
| Value At Risk | (3.81) | |||
| Potential Upside | 7.68 | |||
| Downside Variance | 5.54 | |||
| Semi Variance | 3.33 | |||
| Expected Short fall | (4.15) | |||
| Skewness | 1.64 | |||
| Kurtosis | 4.93 |
Iteos Therapeutics July 21, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Iteos stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.02 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 10.25 | ||
| Day Typical Price | 10.21 | ||
| Price Action Indicator | (0.11) | ||
| Market Facilitation Index | 0.23 |
Additional Tools for Iteos Stock Analysis
When running Iteos Therapeutics' price analysis, check to measure Iteos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iteos Therapeutics is operating at the current time. Most of Iteos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Iteos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iteos Therapeutics' price. Additionally, you may evaluate how the addition of Iteos Therapeutics to your portfolios can decrease your overall portfolio volatility.